417 related articles for article (PubMed ID: 36986635)
1. Approved Nanomedicine against Diseases.
Jia Y; Jiang Y; He Y; Zhang W; Zou J; Magar KT; Boucetta H; Teng C; He W
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986635
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.
Szelenyi I
Inflamm Res; 2012 Jan; 61(1):1-9. PubMed ID: 22057873
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology as a tool to overcome macromolecules delivery issues.
Tundisi LL; Ataide JA; Costa JSR; Coêlho DF; Liszbinski RB; Lopes AM; Oliveira-Nascimento L; de Jesus MB; Jozala AF; Ehrhardt C; Mazzola PG
Colloids Surf B Biointerfaces; 2023 Feb; 222():113043. PubMed ID: 36455361
[TBL] [Abstract][Full Text] [Related]
9. Trends in Nanomedicines for Cancer Treatment.
do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
[TBL] [Abstract][Full Text] [Related]
10. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
13. Veterinary nanomedicine: Pros and cons.
Jafary F; Motamedi S; Karimi I
Vet Med Sci; 2023 Jan; 9(1):494-506. PubMed ID: 36580403
[TBL] [Abstract][Full Text] [Related]
14. Nanotherapeutics in the EU: an overview on current state and future directions.
Hafner A; Lovrić J; Lakoš GP; Pepić I
Int J Nanomedicine; 2014; 9():1005-23. PubMed ID: 24600222
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine-Combined Immunotherapy for Cancer.
Huang S; Zhao Q
Curr Med Chem; 2020; 27(34):5716-5729. PubMed ID: 31250752
[TBL] [Abstract][Full Text] [Related]
16. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Glasgow MD; Chougule MB
J Biomed Nanotechnol; 2015 Nov; 11(11):1859-98. PubMed ID: 26554150
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
Kaur M; Nagpal M; Aggarwal G
Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
